These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39119242)
1. Synthesis of nimbolide and its analogues and their application as poly(ADP-ribose) polymerase-1 trapping inducers. Deng H; Deng H; Kim C; Li P; Wang X; Yu Y; Qin T Nat Synth; 2024 Mar; 3(3):378-385. PubMed ID: 39119242 [TBL] [Abstract][Full Text] [Related]
2. Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in Li P; Zhen Y; Kim C; Liu Z; Hao J; Deng H; Deng H; Zhou M; Wang XD; Qin T; Yu Y Sci Adv; 2023 Oct; 9(43):eadg7752. PubMed ID: 37878693 [TBL] [Abstract][Full Text] [Related]
4. The complex universe of inactive PARP1. Huang D; Su Z; Mei Y; Shao Z Trends Genet; 2024 Dec; 40(12):1074-1085. PubMed ID: 39306519 [TBL] [Abstract][Full Text] [Related]
5. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities. Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948 [TBL] [Abstract][Full Text] [Related]
6. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency. Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579 [TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update. Jain PG; Patel BD Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797 [TBL] [Abstract][Full Text] [Related]
8. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase. Kim IK; Stegeman RA; Brosey CA; Ellenberger T J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519 [TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins. Alemasova EE; Lavrik OI Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503 [TBL] [Abstract][Full Text] [Related]
10. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1]. Kurgina TA; Lavrik OI Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654 [TBL] [Abstract][Full Text] [Related]
11. MORC2 regulates DNA damage response through a PARP1-dependent pathway. Zhang L; Li DQ Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951 [TBL] [Abstract][Full Text] [Related]
12. PAR recognition by PARP1 regulates DNA-dependent activities and independently stimulates catalytic activity of PARP1. Deeksha W; Abhishek S; Rajakumara E FEBS J; 2023 Nov; 290(21):5098-5113. PubMed ID: 37462479 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1. Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956 [TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells. Zhang R; Hong JJ; Yang Q; Ong CT; Li BA; Liou YC Oncogene; 2019 Apr; 38(15):2750-2766. PubMed ID: 30542118 [TBL] [Abstract][Full Text] [Related]
15. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage. Kang HC; Lee YI; Shin JH; Andrabi SA; Chi Z; Gagné JP; Lee Y; Ko HS; Lee BD; Poirier GG; Dawson VL; Dawson TM Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14103-8. PubMed ID: 21825151 [TBL] [Abstract][Full Text] [Related]
16. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer. Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269 [TBL] [Abstract][Full Text] [Related]
17. Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes. Maluchenko N; Koshkina D; Korovina A; Studitsky V; Feofanov A Cells; 2022 Oct; 11(21):. PubMed ID: 36359739 [TBL] [Abstract][Full Text] [Related]
18. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions. Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276 [TBL] [Abstract][Full Text] [Related]
19. TSG101 associates with PARP1 and is essential for PARylation and DNA damage-induced NF-κB activation. Tufan AB; Lazarow K; Kolesnichenko M; Sporbert A; von Kries JP; Scheidereit C EMBO J; 2022 Nov; 41(21):e110372. PubMed ID: 36124865 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage. Matkarimov BT; Zharkov DO; Saparbaev MK Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]